24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
PhaseV
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
13:53
The breach that doesn’t have to happen - and what real cyber warfare looks like
13:42
"We are able to understand what drives cancer. This changes the entire course of the disease"
12:19
Why Disney is licensing AI instead of fighting it
11:53
Israeli healthtech faces a more selective funding market after the war
More stories
Buzz
Most popular
Daily
Weekly
1
Palo Alto Networks CEO: “We’re happy Wiz is now part of Google, it gives us more room to operate”
2
Cyera raises $400 million at $9 billion valuation in Blackstone-led round
3
UAE reportedly behind Elbit’s record $2.3 billion defense deal
4
Vega raises $120 million Series B as two-year-old cyber startup hits $700 million valuation
5
Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal
More news
PhaseV
4 stories about PhaseV
WATCH: CTech's most promising healthtech startups
29.05.25
|
CTech
Here's everything you need to know about Sensi.ai, Briya Labs, PhaseV, Zorro, and DeepCure
PhaseV raises $50 million Series A to rethink how drugs get to market
13.05.25
|
CTech
With over 30 global customers, the AI startup targets inefficiencies in clinical trials.
Here’s how PhaseV uses AI to optimize clinical trials to speed clinical development
27.03.25
|
James Spiro
CEO and Co-Founder Dr. Raviv Pryluk spoke to CTech after being named as one of the Top 10 Israeli startups to watch out for in 2025 at Calcalist’s Mind The Tech conference in New York.
PhaseV raises $15 million to optimize clinical trials with causal machine learning
24.10.23
|
CTech
The Israeli startup detects hidden signals in clinical data and extracts actionable insights for planning the next steps